AKRO Company Profile and Key Details

Q: Who are the executives of AKRO?

Dr. Timothy RolphCo-Founder & Chief Scientific OfficerMr. John J. SchembriVice President of Fin. & ControllerMs. Catriona YaleExecutive Vice President & Chief Devel. OfficerDr. Andrew Cheng M.D., Ph.D.Pres, Chief Executive Officer & DirectorMr. Patrick LamySenior Vice President of Commercial StrategyMr. William R. White J.D.Executive Vice President, Chief Financial Officer, Treasurer & Head of Corporation Devel.Dr. Jonathan M. Young J.D., Ph.D.Co-Founder, Executive Vice President, Chief Operating Officer & Sec.

NASDAQ : AKRO

Akero Therapeutics

$54.65

At Close 4:00 PM

Not Actively Trading

59.61

BESG ScoreESG Rating

Profile Key Stats Analyst Ratings Ownership Ratios Financials Dividend & splits Sentiment Forecast

Price Chart

Stock Price Today

Akero Therapeutics, Inc. (AKRO) stock remained unchanged at $54.65 a share on NASDAQ. The stock opened at $54.52, fluctuating between $54.52 to $54.65 during the session.

Stock Snapshot

54.65

Prev. Close

4.5B

Market Cap

54.52

Day Low

-14.573333333333334

P/E Ratio

-3.75

EPS (TTM)

-2.61

Cash Flow per Share

54.52

Open

82.32M

Number of Shares

54.65

Day High

85.86%

Free Float in %

9.61

Book Value

11.61M

Volume

Relevant Articles

SEC Fillings

Current Report (8-k)

Filing Date	Accepted Date

Annual Report (10-k)

Filing Date	Accepted Date

Stock Price History Chart

Date	Open	High	Low	Close	Volume
Dec 09, 2025	54.52	54.83	54.42	54.65	11.61M
Dec 08, 2025	54.52	54.83	54.37	54.65	14.99M
Dec 05, 2025	54.65	54.65	54.30	54.55	4.68M
Dec 04, 2025	54.68	54.69	54.53	54.63	2.28M
Dec 03, 2025	54.49	54.70	54.44	54.69	3.61M
Dec 02, 2025	54.46	54.52	54.42	54.49	1.8M
Dec 01, 2025	54.35	54.48	54.35	54.44	2M
Nov 28, 2025	54.38	54.44	54.34	54.36	639.26K
Nov 26, 2025	54.34	54.40	54.32	54.35	1.04M
Nov 25, 2025	54.32	54.39	54.31	54.36	706.09K
Nov 24, 2025	54.32	54.41	54.28	54.36	1.66M
Nov 21, 2025	54.28	54.35	54.26	54.31	1.12M
Nov 20, 2025	54.40	54.41	54.22	54.23	1.22M
Nov 19, 2025	54.37	54.40	54.32	54.34	1.37M
Nov 18, 2025	54.31	54.40	54.27	54.33	810.33K
Nov 17, 2025	54.26	54.37	54.24	54.35	1.14M
Nov 14, 2025	54.20	54.37	54.10	54.25	1.77M
Nov 13, 2025	54.25	54.31	54.16	54.20	1.83M
Nov 12, 2025	54.26	54.35	54.22	54.30	1.13M
Nov 11, 2025	54.14	54.30	54.09	54.25	1.51M

Contact Details

South San Francisco, CA 94080

United States

https://www.akerotx.com 650 487 6488

About Company

Akero Therapeutics, Inc. is a biopharmaceutical firm dedicated to addressing cardio-metabolic disorders, with a specific focus on nonalcoholic steatohepatitis (NASH). Its primary objective is the creation of therapeutic agents aimed at re-establishing metabolic equilibrium and enhancing overall well-being. The company's flagship investigational drug is efruxifermin (EFX), a synthetic analog of fibroblast growth factor 21. EFX is designed to shield cells from stress and modulate the systemic metabolism of fats, carbohydrates, and proteins throughout the body. This promising compound is currently undergoing evaluation in a Phase 2a clinical investigation, known as the BALANCED study, for individuals diagnosed with biopsy-confirmed NASH. Originally established as Pippin Pharmaceuticals, Inc., the organization rebranded as Akero Therapeutics, Inc. in May 2018. Founded in 2017, Akero Therapeutics maintains its corporate headquarters in South San Francisco, California.

Stock Peers

ARGX

2.58+0.30%

argenx SE$860.55 REGN

-2.25001-0.33%

Regeneron Pharmaceuticals, Inc.$676.69 MDGL

7.95+1.46%

Madrigal Pharmaceuticals, Inc.$553.48 UTHR

6.62+1.25%

United Therapeutics Corporation$535.67 VRTX

-0.38002-0.08%

Vertex Pharmaceuticals Incorporated$485.65 KRYS

13.07+3.82%

Krystal Biotech, Inc.$354.86 KRTX

0.09+0.03%

Karuna Therapeutics, Inc.$329.83 PRAX

6.21001+2.01%

Praxis Precision Medicines, Inc.$314.41 ONC

-5.4-1.70%

BeOne Medicines AG$312.02 LGND

6.94+2.34%

Ligand Pharmaceuticals Incorporated$303.39

Frequently Asked Questions

What is the current Akero Therapeutics, Inc. (AKRO) stock price?

Akero Therapeutics, Inc. (NASDAQ: AKRO) stock price is $54.65 in the last trading session. During the trading session, AKRO stock reached the peak price of $54.65 while $54.52 was the lowest point it dropped to. The percentage change in AKRO stock occurred in the recent session was 0% while the dollar amount for the price change in AKRO stock was $0.00.

AKRO's industry and sector of operation?

The NASDAQ listed AKRO is part of Biotechnology industry that operates in the broader Healthcare sector. Akero Therapeutics, Inc. designs, manufactures, and markets smartphones, personal computers, tablets, wearables, and accessories worldwide.

Who are the executives of AKRO?

Dr. Timothy Rolph
Co-Founder & Chief Scientific Officer
Mr. John J. Schembri
Vice President of Fin. & Controller
Ms. Catriona Yale
Executive Vice President & Chief Devel. Officer
Dr. Andrew Cheng M.D., Ph.D.
Pres, Chief Executive Officer & Director
Mr. Patrick Lamy
Senior Vice President of Commercial Strategy
Mr. William R. White J.D.
Executive Vice President, Chief Financial Officer, Treasurer & Head of Corporation Devel.
Dr. Jonathan M. Young J.D., Ph.D.
Co-Founder, Executive Vice President, Chief Operating Officer & Sec.

How AKRO did perform over past 52-week?

AKRO's closing price is 156.09% higher than its 52-week low of $21.34 where as its distance from 52-week high of $58.40 is -6.42%.

How many employees does AKRO have?

Number of AKRO employees currently stands at 69.

Link for AKRO official website?

Official Website of AKRO is: https://www.akerotx.com

How do I contact AKRO?

AKRO could be contacted at phone 650 487 6488 and can also be accessed through its website. AKRO operates from 601 Gateway Boulevard, South San Francisco, CA 94080, United States.

How many shares of AKRO are traded daily?

AKRO stock volume for the day was 11.61M shares. The average number of AKRO shares traded daily for last 3 months was 2.56M.

What is the market cap of AKRO currently?

The market value of AKRO currently stands at $4.50B with its latest stock price at $54.65 and 82.32M of its shares outstanding.

Stocks Telegraph provides information and tools designed to assist investors and Wall Street players. A major goal is to offer financiers comprehensive information that will help them gain insight into investing.

Stocks Telegraph does not provide any advice or recommendations for buying or selling stocks, securities, or other financial products. Information contained on this website is for informational purposes only and should not be construed as professional financial, investment or other advice. Stocks Telegraph is not liable for any loss or damage that may occur as a result of reliance on this data.

Employees	69
Beta	-0.4
Sales or Revenue	$0.00
5Y Sales Change%	0%
Fiscal Year Ends	December
Sector	Healthcare
Industry	Biotechnology

Employees	69
Beta	-0.4
Sales or Revenue	$0.00
5Y Sales Change%	0%
Fiscal Year Ends	December
Sector	Healthcare
Industry	Biotechnology

AKRO Company Profile and Key Details

Akero Therapeutics

Price Chart

Stock Price Today

Stock Snapshot

Relevant Articles

SEC Fillings

Current Report (8-k)

Annual Report (10-k)

Stock Price History Chart

Contact Details

About Company

Company Information

Stock Peers

Frequently Asked Questions

Price Chart

Stock Price Today

Stock Snapshot

Relevant Articles

SEC Fillings

Current Report (8-k)

Annual Report (10-k)

Stock Price History Chart

Contact Details

About Company

Company Information

Stock Peers

Company Overview

Technical Performance

Valuation Metrics

Dividend & Fair Value

Earnings & Analyst Outlook

Shareholding & Insider Activity

Financial & Profitability Overview

Quarterly Financial Highlights

Price Forecast & Outlook

Key Takeaways

Frequently Asked Questions

Technical Performance

Earnings & Analyst Outlook

Company Overview

Financial & Profitability Overview

Quarterly Financial Highlights

Dividend & Fair Value

Shareholding & Insider Activity

Valuation Metrics

Price Forecast & Outlook

Key Takeaways